Seminars in Hematology
Volume 46, Supplement 2 , Pages S37-S43, January 2009

Thrombocytopenia in Myelodysplastic Syndromes and Myelofibrosis

  • Adam M. Boruchov

      Affiliations

    • Corresponding Author InformationAddress correspondence to Adam M. Boruchov, MD, University of Connecticut School of Medicine and the Saint Francis Regional Cancer Center, 114 Woodland St, Hartford, CT 06105

Saint Francis Regional Cancer Center, Hartford, CT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Adam M. Boruchov, MD, discloses the following: Consultant: Novartis.

PII: S0037-1963(08)00200-X

doi:10.1053/j.seminhematol.2008.12.001

Seminars in Hematology
Volume 46, Supplement 2 , Pages S37-S43, January 2009

Article Tools